SEC Form 4 
FORM 4	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 	  
OMB APPROVAL
OMB Number:	3235-0287	
Estimated average burden	
hours per response:	0.5	

	
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).			
1. Name and Address of Reporting Person*
AISLING CAPITAL III LP	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	2. Issuer Name and Ticker or Trading Symbol 
SafeStitch Medical, Inc. [ SFES.OB ] 	5. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
	Director	X	10% Owner	
	Officer (give title below)		Other (specify below)	

	3. Date of Earliest Transaction (Month/Day/Year)
09/03/2013 		
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) 
	Form filed by One Reporting Person	
X	Form filed by More than One Reporting Person	
	
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1. Title of Security (Instr. 3) 	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8) 	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 	5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	7. Nature of Indirect Beneficial Ownership (Instr. 4) 	
			Code	V	Amount	(A) or (D)	Price				
Common Stock								24,088,496	I(1) 	By Aisling Capital III, LP(1) 	
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) 	
1. Title of Derivative Security (Instr. 3) 	2. Conversion or Exercise Price of Derivative Security 	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8) 	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 	6. Date Exercisable and Expiration Date (Month/Day/Year)	7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 	8. Price of Derivative Security (Instr. 5) 	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 	11. Nature of Indirect Beneficial Ownership (Instr. 4) 	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
Series B Preferred Stock	$0.4(2) 	09/03/2013		P		1,240,176.4(2) 		(2) 	(3) 	Common Stock	12,401,764	$4 	1,240,176.4	I(1) 	By Aisling Capital III, LP(1) 	
1. Name and Address of Reporting Person*
AISLING CAPITAL III LP	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
1. Name and Address of Reporting Person*
Aisling Capital Partners III LP	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
1. Name and Address of Reporting Person*
Aisling Capital Partners III LLC	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
1. Name and Address of Reporting Person*
SCHIFF ANDREW N	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
1. Name and Address of Reporting Person*
ELMS STEVE	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
1. Name and Address of Reporting Person*
Purcell Dennis J	

(Last)	(First)	(Middle)	
888 SEVENTH AVENUE, 30TH FLOOR	

(Street) 
NEW YORK	NY	10106	

(City)	(State)	(Zip)	
	
Explanation of Responses:	
1. The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.	
2. September 3, 2013, SafeStitch Medical, Inc. (the "Issuer") sold and issued to Aisling Capital III LP, in a privately negotiated transaction pursuant to a securities purchase agreement, an aggregate of 1,240,176.4 shares of the Issuer's Series B convertible preferred stock at a purchase price of $4.00 per share. Upon the filing of an Amendment to the Issuer's Certificate of Incorporation with the State of Delaware, each share of the Issuer's Series B convertible preferred stock will automatically convert into ten (10) shares of the Issuer's common stock.	
3. The Series B Preferred Stock has no expiration date.	
Remarks:	
	
	/s/ Lloyd Appel, Aisling Capital III, LP	09/03/2013	
	** Signature of Reporting Person	Date	
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).	
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.	

Exhibit 99

Form 4 Joint Filer Information

Name:   Aisling Capital Partners III, LP

Address:   888 Seventh Avenue, 30th Floor
           New York, NY  10106

Designated Filer:   Aisling Capital III LP

Issuer & Ticker Symbol:   SafeStitch Medical, Inc. (SFES.OB)

Date of Event Requiring Statement:   09/03/2013

Signature:   /s/ Lloyd Appel, Aisling Capital Partners III, LP, as general
partner of Aisling Capital III, LP

Name:   Aisling Capital Partners III LLC

Address:   888 Seventh Avenue, 30th Floor
           New York, NY  10106

Designated Filer:   Aisling Capital III LP

Issuer & Ticker Symbol:   SafeStitch Medical, Inc. (SFES.OB)

Date of Event Requiring Statement:   09/03/2013

Signature:   /s/ Lloyd Appel, Aisling Capital Partners III LLC, as general
partner of Aisling Capital Partners III, LP

Name:   Andrew N. Schiff

Address:   888 Seventh Avenue, 30th Floor
           New York, NY  10106

Designated Filer:   Aisling Capital III LP

Issuer & Ticker Symbol:   SafeStitch Medical, Inc. (SFES.OB)

Date of Event Requiring Statement:   09/03/2013

Signature:   /s/ Andrew N. Schiff

Name:   Dennis J. Purcell

Address:   888 Seventh Avenue, 30th Floor
           New York, NY  10106

Designated Filer:   Aisling Capital III LP

Issuer & Ticker Symbol:   SafeStitch Medical, Inc. (SFES.OB)

Date of Event Requiring Statement:   09/03/2013

Signature:   /s/ Dennis J. Purcell

Name:   Steve Elms

Address:   888 Seventh Avenue, 30th Floor
           New York, NY  10106

Designated Filer:   Aisling Capital III LP

Issuer & Ticker Symbol:   SafeStitch Medical, Inc. (SFES.OB)

Date of Event Requiring Statement:   09/03/2013

Signature:   /s/ Steve Elms